The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial

The aim of present study was to evaluate the effects of the probiotic Lactobacillus fermentum ME-3 on composition of gut microbiota and urine polyamines level. The healthy volunteers were divided into two groups: probiotic group received kefir with L. fermentum ME-3 and control group regular kefir b...

Full description

Bibliographic Details
Main Authors: Epp Sepp, Imbi Smidt, Jelena Štšepetova, Tiiu Rööp, Pirje Hütt, Merle Rätsep, Marika Mikelsaar
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464618301920
_version_ 1828933217225277440
author Epp Sepp
Imbi Smidt
Jelena Štšepetova
Tiiu Rööp
Pirje Hütt
Merle Rätsep
Marika Mikelsaar
author_facet Epp Sepp
Imbi Smidt
Jelena Štšepetova
Tiiu Rööp
Pirje Hütt
Merle Rätsep
Marika Mikelsaar
author_sort Epp Sepp
collection DOAJ
description The aim of present study was to evaluate the effects of the probiotic Lactobacillus fermentum ME-3 on composition of gut microbiota and urine polyamines level. The healthy volunteers were divided into two groups: probiotic group received kefir with L. fermentum ME-3 and control group regular kefir both for 8 weeks. The lactoflora was determined by bacteriological method, gut microbiota by real-time PCR and urine polyamines level by gas-chromatography. In probiotic group there was an increase in the richness (p = 0.025), diversity (p = 0.017) and counts (p = 0.003) of lactoflora. That was associated with the increase of the diversity of the whole gut microbiota (p = 0.003). After probiotic consumption the level of urine putrescine had negative correlation with counts of lactobacilli (r = −0.424; p = 0.0083) and bifidobacteria (r = −0.415; p = 0.00983). L. fermentum ME-3 has potential to lower the risk of gut diseases that are bound with lower richness and diversity of gut microbiota and higher putrescine level.
first_indexed 2024-12-14T01:12:53Z
format Article
id doaj.art-7a03e98810274ddba747f78262302b06
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-12-14T01:12:53Z
publishDate 2018-09-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-7a03e98810274ddba747f78262302b062022-12-21T23:22:41ZengElsevierJournal of Functional Foods1756-46462018-09-0148430438The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trialEpp Sepp0Imbi Smidt1Jelena Štšepetova2Tiiu Rööp3Pirje Hütt4Merle Rätsep5Marika Mikelsaar6Corresponding author.; Department of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaDepartment of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaDepartment of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaDepartment of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaDepartment of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaDepartment of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaDepartment of Microbiology, University of Tartu, Ravila 19, 50411 Tartu, EstoniaThe aim of present study was to evaluate the effects of the probiotic Lactobacillus fermentum ME-3 on composition of gut microbiota and urine polyamines level. The healthy volunteers were divided into two groups: probiotic group received kefir with L. fermentum ME-3 and control group regular kefir both for 8 weeks. The lactoflora was determined by bacteriological method, gut microbiota by real-time PCR and urine polyamines level by gas-chromatography. In probiotic group there was an increase in the richness (p = 0.025), diversity (p = 0.017) and counts (p = 0.003) of lactoflora. That was associated with the increase of the diversity of the whole gut microbiota (p = 0.003). After probiotic consumption the level of urine putrescine had negative correlation with counts of lactobacilli (r = −0.424; p = 0.0083) and bifidobacteria (r = −0.415; p = 0.00983). L. fermentum ME-3 has potential to lower the risk of gut diseases that are bound with lower richness and diversity of gut microbiota and higher putrescine level.http://www.sciencedirect.com/science/article/pii/S1756464618301920ProbioticGut lactofloraGut microbesPolyamine
spellingShingle Epp Sepp
Imbi Smidt
Jelena Štšepetova
Tiiu Rööp
Pirje Hütt
Merle Rätsep
Marika Mikelsaar
The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial
Journal of Functional Foods
Probiotic
Gut lactoflora
Gut microbes
Polyamine
title The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial
title_full The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial
title_fullStr The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial
title_full_unstemmed The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial
title_short The effect of Lactobacillus fermentum ME-3 on the intestinal microbiota and urine polyamines content: A double-blind placebo-controlled pilot trial
title_sort effect of lactobacillus fermentum me 3 on the intestinal microbiota and urine polyamines content a double blind placebo controlled pilot trial
topic Probiotic
Gut lactoflora
Gut microbes
Polyamine
url http://www.sciencedirect.com/science/article/pii/S1756464618301920
work_keys_str_mv AT eppsepp theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT imbismidt theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT jelenastsepetova theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT tiiuroop theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT pirjehutt theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT merleratsep theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT marikamikelsaar theeffectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT eppsepp effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT imbismidt effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT jelenastsepetova effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT tiiuroop effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT pirjehutt effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT merleratsep effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial
AT marikamikelsaar effectoflactobacillusfermentumme3ontheintestinalmicrobiotaandurinepolyaminescontentadoubleblindplacebocontrolledpilottrial